The administration of IL-23 resulted in a notable elevation in the accumulation of CD133+ cells and the activation of Wnt and Notch signaling pathways in ESCC CD133-IL-23R+ cell lines. The gene discussed is IL23A; the disease is esophageal squamous cell carcinoma.